TrialMedical oncology (Northwood, London, England)2021
Metabolic shift of chronic myeloid leukemia patients under imatinib-pioglitazone regimen and discontinuation.
Valquíria Mariane Oliveira Póvoa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it